Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27


Immunomodulatory Effects of Stereotactic Body Radiation Therapy (SBRT): Preclinical Insights and Clinical Opportunities.

Marciscano AE, Haimovitz-Friedman A, Lee P, Tran PT, Tomé WA, Guha C, Kong FS, Sahgal A, El Naqa I, Rimner A, Marks LB, Formenti SC, DeWeese TL.

Int J Radiat Oncol Biol Phys. 2019 Mar 2. pii: S0360-3016(19)30290-1. doi: 10.1016/j.ijrobp.2019.02.046. [Epub ahead of print]


Role of noninvasive molecular imaging in determining response.

Marciscano AE, Thorek DLJ.

Adv Radiat Oncol. 2018 Oct 23;3(4):534-547. doi: 10.1016/j.adro.2018.07.006. eCollection 2018 Oct-Dec. Review.


The Winds of Change: Emerging Therapeutics in Prostate Cancer.

Pezaro CJ, Marciscano AE, Madan RA.

Am Soc Clin Oncol Educ Book. 2018 May 23;(38):382-390. doi: 10.1200/EDBK_201295. Review.


White paper on microbial anti-cancer therapy and prevention.

Forbes NS, Coffin RS, Deng L, Evgin L, Fiering S, Giacalone M, Gravekamp C, Gulley JL, Gunn H, Hoffman RM, Kaur B, Liu K, Lyerly HK, Marciscano AE, Moradian E, Ruppel S, Saltzman DA, Tattersall PJ, Thorne S, Vile RG, Zhang HH, Zhou S, McFadden G.

J Immunother Cancer. 2018 Aug 6;6(1):78. doi: 10.1186/s40425-018-0381-3.


Avelumab: is it time to get excited?

Marciscano AE, Gulley JL, Kaufman HL.

Expert Rev Anticancer Ther. 2018 Sep;18(9):815-821. doi: 10.1080/14737140.2018.1493380. Epub 2018 Jul 2. No abstract available.


Elective Nodal Irradiation Attenuates the Combinatorial Efficacy of Stereotactic Radiation Therapy and Immunotherapy.

Marciscano AE, Ghasemzadeh A, Nirschl TR, Theodros D, Kochel CM, Francica BJ, Muroyama Y, Anders RA, Sharabi AB, Velarde E, Mao W, Chaudhary KR, Chaimowitz MG, Wong J, Selby MJ, Thudium KB, Korman AJ, Ulmert D, Thorek DLJ, DeWeese TL, Drake CG.

Clin Cancer Res. 2018 Oct 15;24(20):5058-5071. doi: 10.1158/1078-0432.CCR-17-3427. Epub 2018 Jun 13.


Effects of perineural invasion on biochemical recurrence and prostate cancer-specific survival in patients treated with definitive external beam radiotherapy.

Peng LC, Narang AK, Gergis C, Radwan NA, Han P, Marciscano AE, Robertson SP, He P, Trieu J, Ram AN, McNutt TR, Griffith E, DeWeese TA, Honig S, Singh H, Greco SC, Tran PT, Deville C, DeWeese TL, Song DY.

Urol Oncol. 2018 Jun;36(6):309.e7-309.e14. doi: 10.1016/j.urolonc.2018.02.008. Epub 2018 Mar 16.


Targeting the Tumor Microenvironment with Immunotherapy for Genitourinary Malignancies.

Marciscano AE, Madan RA.

Curr Treat Options Oncol. 2018 Mar 8;19(3):16. doi: 10.1007/s11864-018-0523-3. Review.


Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.

Chen L, Douglass J, Kleinberg L, Ye X, Marciscano AE, Forde PM, Brahmer J, Lipson E, Sharfman W, Hammers H, Naidoo J, Bettegowda C, Lim M, Redmond KJ.

Int J Radiat Oncol Biol Phys. 2018 Mar 15;100(4):916-925. doi: 10.1016/j.ijrobp.2017.11.041. Epub 2017 Dec 5.


TNFα and Radioresistant Stromal Cells Are Essential for Therapeutic Efficacy of Cyclic Dinucleotide STING Agonists in Nonimmunogenic Tumors.

Francica BJ, Ghasemzadeh A, Desbien AL, Theodros D, Sivick KE, Reiner GL, Hix Glickman L, Marciscano AE, Sharabi AB, Leong ML, McWhirter SM, Dubensky TW Jr, Pardoll DM, Drake CG.

Cancer Immunol Res. 2018 Apr;6(4):422-433. doi: 10.1158/2326-6066.CIR-17-0263. Epub 2018 Feb 22.


Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshop.

Marciscano AE, Walker JM, McGee HM, Kim MM, Kunos CA, Monjazeb AM, Shiao SL, Tran PT, Ahmed MM.

J Immunother Cancer. 2018 Jan 29;6(1):6. doi: 10.1186/s40425-018-0317-y.


Avelumab demonstrates promise in advanced NSCLC.

Marciscano AE, Gulley JL.

Oncotarget. 2017 Nov 13;8(61):102767-102768. doi: 10.18632/oncotarget.22418. eCollection 2017 Nov 28. No abstract available.


Stereotactic Radiotherapy Increases Functionally Suppressive Regulatory T Cells in the Tumor Microenvironment.

Muroyama Y, Nirschl TR, Kochel CM, Lopez-Bujanda Z, Theodros D, Mao W, Carrera-Haro MA, Ghasemzadeh A, Marciscano AE, Velarde E, Tam AJ, Thoburn CJ, Uddin M, Meeker AK, Anders RA, Pardoll DM, Drake CG.

Cancer Immunol Res. 2017 Nov;5(11):992-1004. doi: 10.1158/2326-6066.CIR-17-0040. Epub 2017 Oct 2.


Long-term Treatment Response and Patient Outcomes for Vestibular Schwannoma Patients Treated with Hypofractionated Stereotactic Radiotherapy.

Patel MA, Marciscano AE, Hu C, Jusué-Torres I, Garg R, Rashid A, Francis HW, Lim M, Redmond KJ, Rigamonti D, Kleinberg LR.

Front Oncol. 2017 Sep 4;7:200. doi: 10.3389/fonc.2017.00200. eCollection 2017.


Evaluating Post-Radiotherapy Laryngeal Function with Laryngeal Videostroboscopy in Early Stage Glottic Cancer.

Marciscano AE, Charu V, Starmer HM, Best SR, Quon H, Hillel AT, Akst LM, Kiess AP.

Front Oncol. 2017 Jun 12;7:124. doi: 10.3389/fonc.2017.00124. eCollection 2017.


LAG3 (CD223) as a cancer immunotherapy target.

Andrews LP, Marciscano AE, Drake CG, Vignali DA.

Immunol Rev. 2017 Mar;276(1):80-96. doi: 10.1111/imr.12519. Review.


Long-term Outcomes With Planned Multistage Reduced Dose Repeat Stereotactic Radiosurgery for Treatment of Inoperable High-Grade Arteriovenous Malformations: An Observational Retrospective Cohort Study.

Marciscano AE, Huang J, Tamargo RJ, Hu C, Khattab MH, Aggarwal S, Lim M, Redmond KJ, Rigamonti D, Kleinberg LR.

Neurosurgery. 2017 Jul 1;81(1):136-146. doi: 10.1093/neuros/nyw041.


Imaging and extent of surgical resection predict risk of meningioma recurrence better than WHO histopathological grade.

Hwang WL, Marciscano AE, Niemierko A, Kim DW, Stemmer-Rachamimov AO, Curry WT, Barker FG 2nd, Martuza RL, Loeffler JS, Oh KS, Shih HA, Larvie M.

Neuro Oncol. 2016 Jun;18(6):863-72. doi: 10.1093/neuonc/nov285. Epub 2015 Nov 22.


Benign meningiomas (WHO Grade I) with atypical histological features: correlation of histopathological features with clinical outcomes.

Marciscano AE, Stemmer-Rachamimov AO, Niemierko A, Larvie M, Curry WT, Barker FG 2nd, Martuza RL, McGuone D, Oh KS, Loeffler JS, Shih HA.

J Neurosurg. 2016 Jan;124(1):106-14. doi: 10.3171/2015.1.JNS142228. Epub 2015 Aug 14.


Antiangiogenic Therapies and Extracranial Metastasis in Glioblastoma: A Case Report and Review of the Literature.

Khattab MH, Marciscano AE, Lo SS, Lim M, Laterra JJ, Kleinberg LR, Redmond KJ.

Case Rep Oncol Med. 2015;2015:431819. doi: 10.1155/2015/431819. Epub 2015 Jun 23.


3D quantitative assessment of response to fractionated stereotactic radiotherapy and single-session stereotactic radiosurgery of vestibular schwannoma.

Schneider T, Chapiro J, Lin M, Geschwind JF, Kleinberg L, Rigamonti D, Jusué-Torres I, Marciscano AE, Yousem DM.

Eur Radiol. 2016 Mar;26(3):849-57. doi: 10.1007/s00330-015-3895-9. Epub 2015 Jul 3.


Development of a novel multiplexed assay for quantification of transforming growth factor-β (TGF-β).

Pellicciotta I, Marciscano AE, Hardee ME, Francis D, Formenti S, Barcellos-Hoff MH.

Growth Factors. 2015 Apr;33(2):79-91. doi: 10.3109/08977194.2014.999367. Epub 2015 Jan 14.


Stereotactic body radiation therapy in pancreatic cancer: the new frontier.

Moningi S, Marciscano AE, Rosati LM, Ng SK, Teboh Forbang R, Jackson J, Chang DT, Koong AC, Herman JM.

Expert Rev Anticancer Ther. 2014 Dec;14(12):1461-75. doi: 10.1586/14737140.2014.952286. Epub 2014 Sep 3. Review.


Torus palatinus.

Vaduganathan M, Marciscano AE, Olson KR.

Proc (Bayl Univ Med Cent). 2014 Jul;27(3):259. No abstract available.


Resistance of glioblastoma-initiating cells to radiation mediated by the tumor microenvironment can be abolished by inhibiting transforming growth factor-β.

Hardee ME, Marciscano AE, Medina-Ramirez CM, Zagzag D, Narayana A, Lonning SM, Barcellos-Hoff MH.

Cancer Res. 2012 Aug 15;72(16):4119-29. doi: 10.1158/0008-5472.CAN-12-0546. Epub 2012 Jun 12.


Introduction to the medical professions through an innovative medical student-run pipeline program.

Nair N, Marciscano AE, Vivar KL, Schaeffer S, LaMont E, Francois F.

J Natl Med Assoc. 2011 Sep-Oct;103(9-10):832-8.


Management of high-risk localized prostate cancer.

Marciscano AE, Hardee ME, Sanfilippo N.

Adv Urol. 2012;2012:641689. doi: 10.1155/2012/641689. Epub 2011 Nov 1.

Supplemental Content

Loading ...
Support Center